Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
FB Financial Q1 2026 Earnings Call - Loan pipeline momentum points to mid-to-high single-digit growth despite deposit pricing pressure
FB Financial closed Q1 with solid profitability and an improving growth backdrop, even as margin pressure from aggressive deposit pricing cropped up across its markets. Reported EPS was $1.10 (adjuste...
- Reported EPS $1.10, adjusted EPS $1.12; net income $57.5 million (adjusted $58.3 million).
- Pre-tax, pre-provision net revenue (PPNR) $77.2 million ($78.2 million adjusted); PPNR return on average assets ~1.93%-1.95%.
- Management says loan and deposit growth picked up in March, with pipelines improving and momentum expected to be weighted to the second half of 2026.
- +16 more takeaways
CarMax Q4 FY2026 Earnings Call - Price Cuts Restarted Sales Momentum while Restructuring and Goodwill Hit EPS
CarMax closed FY2026 with a clear tactical pivot: aggressive price cuts, higher acquisition marketing, and digital fixes reversed a multi-quarter sales slide and produced a meaningful change in trend....
- Company leadership change: Keith Barr, former IHG Hotels CEO, named President and CEO, emphasizing customer-first, omni-channel and tech-led transformation; strategic update expected starting around June.
- Q4 results: total sales $5.9 billion, down 1% year over year; combined retail and wholesale vehicle sales ~304,000 units, up 1% year over year.
- Retail dynamics: retail unit sales declined 0.8% and used unit comps were down 1.9% in Q4, a marked improvement from Q2 and Q3 where comps were -6.3% and -9% respectively.
- +11 more takeaways
Creative Realities Q4 2025 Earnings Call - CDM deal catapults scale, ARR and synergies; company targets >$100M revenue in 2026
Creative Realities closed 2025 with a transformed footprint after the November acquisition of CDM, which more than doubled the company, lifted Q4 revenue to $23.9 million and pushed ARR to $20.1 milli...
- CDM acquisition more than doubled company size and contributed $13.6 million of Q4 revenue, accelerating scale and Canadian market penetration.
- Q4 2025 revenue was $23.9 million versus $11.0 million in Q4 2024, with consolidated gross profit of $11.5 million and gross margin of 47.9%.
- Annual recurring revenue run rate (ARR) reached $20.1 million as of December 31, 2025, up from $12.3 million at the end of Q3; an additional $4.1 million of SaaS is under contract to come online through 2026.
- +12 more takeaways
JPMorgan Chase Q1 2026 Earnings Call - Regulators’ Basel III and GSIB Reproposal Could Add About $20B in Capital Costs
JPMorgan reported a strong quarter: $16.5 billion net income, $5.94 EPS, and ROTCE of 23% on $50.5 billion revenue, driven by markets, investment banking and asset management. Expenses rose 14% on hig...
- Net income $16.5 billion, EPS $5.94, ROTCE 23% for Q1 2026 on $50.5 billion revenue, up 10% year over year.
- Expenses totaled $26.9 billion, up 14% year over year, driven by higher compensation, revenue-related pay, front-office hiring, brokerage and distribution fees, and the absence of a prior-year FDIC accrual release.
- Credit costs were $2.5 billion, with net charge-offs of $2.3 billion and a net reserve build of $191 million.
- +16 more takeaways
Johnson & Johnson Q1 2026 Earnings Call - Off to $100B Start, ikotide Launch and Oncology/M&Tech Momentum Set Up Bigger Upside
Johnson & Johnson beat Q1 expectations and nudged full-year guidance higher, reporting $24.1 billion in sales and 6.4% operational growth. Management leaned hard into a single storyline, that new laun...
- Q1 results: Worldwide sales $24.1 billion, operational sales growth 6.4%, management says results beat consensus and raised full-year guidance.
- Full-year guidance raised: operational sales 5.9% to 6.9% (midpoint $100.2 billion), reported sales growth 6.5% to 7.5% (midpoint $100.8 billion); adjusted EPS guidance raised $0.02 to $11.30–$11.50 (midpoint $11.55).
- Stelara pain: Stelara drove a material headwind, cited as roughly 540 basis points to worldwide growth and approximately 920 basis points inside Innovative Medicine, with sales down roughly 61.7% due to biosimilar competition and mix shifts.
- +15 more takeaways
Albertsons Companies Q4 FY2025 Earnings Call - Pharmacy IRA Trimmed Sales; Productivity and AI Drove an EBITDA Beat and Bigger Returns
Albertsons closed FY2025 with a muted top-line but a sturdy bottom-line. Pharmacy pressures tied to the Inflation Reduction Act and a quicker-than-expected shift to generics knocked roughly 145 basis ...
- Q4 adjusted EBITDA beat at $903 million, including ~$68 million from the 53rd week; Q4 adjusted EPS was $0.48 per diluted share.
- Full-year FY2025 adjusted EBITDA was $3.9 billion; identical-store sales for the year rose 2.0%.
- Pharmacy produced an approximate 145 basis point headwind to Q4 identical-store sales, driven by ~105 bps from the Inflation Reduction Act (IRA) and generic mix, plus ~40 bps from GLP-1 moderation.
- +13 more takeaways
Leifras Corporation FY2025 Earnings Call - Positioned to Capture Japan’s Club-Activity Privatization Tailwind
Leifras closed FY2025 with record revenue of $74.8 million and materially higher profitability, driven by a 32.8% surge in its social business and sustained strength in its sports school unit. Managem...
- Net revenue rose 13.5% year-on-year to $74.8 million in FY2025, with operating income up 20.7% to $4.0 million and adjusted income from operations up 41.8% to $4.4 million after excluding IPO-related one-offs.
- Social business was the growth engine, with revenue up 32.8%, while the foundational sports school business grew 7.8%—a hybrid portfolio delivering double-digit top-line growth and positive operating leverage.
- Management highlights a structural market opportunity: Japan’s reform to transfer holiday club activities to private/community providers, with a TAM of about 9,800 schools and an addressable market of roughly $3.19 billion.
- +11 more takeaways
New Horizon Aircraft Fiscal Third Quarter 2022 Earnings Call - Full‑scale prototype due by year‑end to launch ground tests and early 2027 flight program
Management doubled down on a near-term engineering sprint: the company expects to complete its full-scale Cavorite X7 prototype by year-end, a milestone they say will lead to ground testing and the st...
- Management reiterated a top near-term goal: complete the full-scale Cavorite X7 prototype by year-end, enabling ground testing and planned flight testing in early 2027.
- Company positions hybrid-electric, turbine-plus-electric architecture as core differentiation, arguing it delivers range, payload and operational flexibility beyond pure-electric eVTOLs.
- Hybrid design intended to remove dependence on ground charging and vertiport buildout, because the turbine can recharge systems airborne and after landing.
- +11 more takeaways
Rent the Runway Q4 2025 Earnings Call - Inventory Bet Delivered Subscriber Growth; Pivoting to AI Discovery and Revenue Diversification
Rent the Runway says its biggest-ever inventory investment worked. Q4 and FY25 showed a return to subscriber growth, higher engagement and improved margins, fueled by more SKUs, price increases, and a...
- Management completed the largest inventory investment in company history in FY25 and attributes a 20% year-over-year increase in ending active subscribers to that strategy, finishing Q4 2025 with 143,796 subscribers.
- Subscription Net Promoter Score rose 39% year-over-year and has more than tripled since 2022, evidence management cites for improved customer experience and loyalty.
- Inventory-related cancellations fell 7.6% year-over-year in Q4, and average app visits per subscriber jumped to 15 per month, roughly 50% higher than 2024 levels, signaling higher engagement.
- +12 more takeaways
AstroNova Q4 FY2026 Earnings Call - Product ID turnaround gains traction, aerospace royalty expiry to add ~$2M to gross profit
AstroNova called fiscal 2026 a foundational reset year, and the numbers show a second-half pickup. Q4 revenue was $37.5 million, full-year revenue was $150.5 million versus $151.3 million a year earli...
- Q4 revenue $37.5 million; full-year revenue $150.5 million versus $151.3 million prior year.
- Company describes FY2026 as a foundational reset, with meaningful operational changes and culture shift toward customer centricity and data-driven decisions.
- Product Identification is showing early signs of a turnaround: Product ID orders $27.5 million, up $2.9 million year-over-year, book-to-bill 104%.
- +15 more takeaways